GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zealand Pharma A/S (OCSE:ZEAL) » Definitions » Market Cap

Zealand Pharma A/S (OCSE:ZEAL) Market Cap : kr38,732.2 Mil (As of Apr. 29, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Zealand Pharma A/S Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zealand Pharma A/S's share price for the quarter that ended in Dec. 2023 was kr373.2. Zealand Pharma A/S's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 58.4 Mil. Therefore, Zealand Pharma A/S's market cap for the quarter that ended in Dec. 2023 was kr21,786.7 Mil.

Zealand Pharma A/S's quarterly market cap increased from Jun. 2023 (kr14,251.1 Mil) to Sep. 2023 (kr17,828.0 Mil) and increased from Sep. 2023 (kr17,828.0 Mil) to Dec. 2023 (kr21,786.7 Mil).

Zealand Pharma A/S's annual market cap increased from Dec. 2021 (kr6,270.6 Mil) to Dec. 2022 (kr10,366.5 Mil) and increased from Dec. 2022 (kr10,366.5 Mil) to Dec. 2023 (kr21,786.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zealand Pharma A/S's Enterprise Value for Today is kr37,218.4 Mil.


Zealand Pharma A/S Market Cap Historical Data

The historical data trend for Zealand Pharma A/S's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zealand Pharma A/S Market Cap Chart

Zealand Pharma A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,472.14 8,779.81 6,270.63 10,366.46 21,786.67

Zealand Pharma A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,366.46 11,120.82 14,251.11 17,827.96 21,786.67

Competitive Comparison of Zealand Pharma A/S's Market Cap

For the Biotechnology subindustry, Zealand Pharma A/S's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zealand Pharma A/S's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zealand Pharma A/S's Market Cap distribution charts can be found below:

* The bar in red indicates where Zealand Pharma A/S's Market Cap falls into.



Zealand Pharma A/S Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Zealand Pharma A/S's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=kr373.2*58.378
=kr21,786.7

Zealand Pharma A/S's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=kr373.2*58.378
=kr21,786.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zealand Pharma A/S  (OCSE:ZEAL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Zealand Pharma A/S Market Cap Related Terms

Thank you for viewing the detailed overview of Zealand Pharma A/S's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Zealand Pharma A/S (OCSE:ZEAL) Business Description

Traded in Other Exchanges
Address
Sydmarken 11, Soborg, DNK, DK-2860
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, which is being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.

Zealand Pharma A/S (OCSE:ZEAL) Headlines

From GuruFocus

Zealand Pharma completes registration of capital increase

By GuruFocusNews GuruFocusNews 07-03-2022

Zealand Pharma to Participate in Upcoming Investor Conferences

By PurpleRose PurpleRose 07-13-2022